Scinnohub Pharmaceutical Co., Ltd.

This early-stage study is testing a new injection called BT-114143 to see if it is safe and can reduce heavy menstrual bleeding. It will involve 39 adult women with diagnosed heavy bleeding. Researchers will give different doses of the injection or a placebo to compare effects on…

This study is testing whether a new drug called BT-114143 can safely reduce blood loss during and after knee replacement surgery. It will compare two different doses of the new drug against a standard medication (tranexamic acid) in 270 adults having the surgery. The main goal is…